Biora Therapeutics (BIOR) News Today → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free BIOR Stock Alerts $1.10 -0.07 (-5.98%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBIOR: Negotiations Acceleratingfinance.yahoo.com - March 27 at 8:19 PMBiora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 27 at 3:19 PMBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Resultsfinanznachrichten.de - March 27 at 10:19 AMBiora Therapeutics: Q4 Earnings Insightsbenzinga.com - March 27 at 10:19 AMQ4 2023 Biora Therapeutics Inc Earnings Callfinance.yahoo.com - March 27 at 10:19 AMBiora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 26 at 4:05 PMHere's what Wall Street expects from Biora Therapeutics's earningsmarkets.businessinsider.com - March 25 at 3:39 PMBiora Therapeutics (BIOR) Scheduled to Post Earnings on Tuesdayamericanbankingnews.com - March 24 at 1:26 AMBiora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Updateglobenewswire.com - March 18 at 8:00 AMBiora Therapeutics announces new capital investmentmsn.com - March 11 at 9:00 AMBiora Therapeutics Further Reduces Net Debt and Monetizes Legacy Assetglobenewswire.com - March 11 at 8:00 AMBIOR Jul 2024 4.000 callfinance.yahoo.com - March 7 at 7:43 PMBIOR Apr 2024 2.500 putfinance.yahoo.com - March 7 at 7:43 PMBIOR Apr 2024 1.000 putfinance.yahoo.com - March 7 at 2:37 AMBIOR Oct 2024 2.000 callfinance.yahoo.com - March 7 at 2:37 AMBIOR Oct 2024 4.000 putca.finance.yahoo.com - March 3 at 7:06 PMBiora Therapeutics Inc Ordinary Shares BIORmorningstar.com - March 1 at 8:10 PMBiora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600finance.yahoo.com - February 26 at 8:20 AMBiora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600globenewswire.com - February 26 at 8:00 AMHere's what Wall Street expects from iRhythm Technologies's earnings reportmarkets.businessinsider.com - February 21 at 2:27 PMBIOR Mar 2024 1.000 callfinance.yahoo.com - February 17 at 1:35 AMBiora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposiumfinance.yahoo.com - February 8 at 10:38 AMBiora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.finance.yahoo.com - January 22 at 8:38 AMBiora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600finance.yahoo.com - January 8 at 9:27 AMBiora Therapeutics Inc Ordinary Sharesmorningstar.com - January 5 at 1:38 PMBiora Therapeutics Stock (NASDAQ:BIOR), Analyst Ratings, Price Targets, Predictionsbenzinga.com - January 4 at 2:59 PMBiora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platformfinance.yahoo.com - January 2 at 8:12 AMBiora Therapeutics to sell 71.07M shares for holdersmsn.com - December 22 at 7:04 PMBIOR: Capitalizing on Progress: BT-600 to Startfinance.yahoo.com - December 20 at 10:51 AMBiora Therapeutics, Inc.: Biora Therapeutics Announces New Patent for its NaviCap Targeted Oral Delivery Platformfinanznachrichten.de - December 19 at 9:41 AMBiora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platformfinance.yahoo.com - December 19 at 9:41 AMBiora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investorsfinance.yahoo.com - December 18 at 8:45 AMBiora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platformfinance.yahoo.com - December 11 at 8:42 AMFDA clears IND for Biora Therapeutics’s ulcerative colitis drugmsn.com - December 1 at 7:43 PMWhy Is Chronic Disease Focused Biora Therapeutics Stock Trading Higher Today?msn.com - December 1 at 2:43 PMFDA Clears Biora's IND Application For BT-600 In Ulcerative Colitis Treatment; Stock Surgesmarkets.businessinsider.com - November 30 at 11:43 PMBiora Therapeutics Application for Ulcerative Colitis Treatment Gets FDA Clearancemarketwatch.com - November 30 at 6:43 PMFDA clears Biora to begin Phase 1 testing of ulcerative colitis treatmentmsn.com - November 30 at 6:43 PMBiora Therapeutics Shares Rise 64% After FDA Clears Application for Ulcerative Colitis Treatmentmarketwatch.com - November 30 at 6:43 PMBiora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitisfinance.yahoo.com - November 30 at 6:43 PMBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 16 at 8:07 AMBIOR: 3Q:23 Resultsmsn.com - November 14 at 11:48 AMBiora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 11:48 AMQ3 2023 Biora Therapeutics Inc Earnings Callfinance.yahoo.com - November 14 at 8:38 AMBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 5:23 PMRecap: Biora Therapeutics Q3 Earningsbenzinga.com - November 13 at 5:23 PMBiora Therapeutics GAAP EPS of -$4.89 misses by $3.96msn.com - November 13 at 5:23 PMBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 5:23 PMBiora Therapeutics earnings: here's what Wall Street expectsmarkets.businessinsider.com - November 12 at 10:20 AMEarnings Outlook For Biora Therapeuticsbenzinga.com - November 10 at 2:00 PM Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BIOR Media Mentions By Week BIOR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOR News Sentiment▼0.420.60▲Average Medical News Sentiment BIOR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOR Articles This Week▼112▲BIOR Articles Average Week Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Acasti Pharma News Today Neoleukin Therapeutics News Today eFFECTOR Therapeutics News Today SELLAS Life Sciences Group News Today Spruce Biosciences News Today Aptorum Group News Today LianBio News Today DURECT News Today VYNE Therapeutics News Today Acurx Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.